PCSK9 & Cardiovascular Disease Risk
November 5, 2019
Written by Maya Sankaran
Written by Maya Sankaran
Variation in serum PCSK9, cardiovascular disease risk and potential unanticipated effects of PCSK9 inhibition: A GWAS and Mendelian randomization study in the HUNT study, Norway.
Browse news by region:
- Africa (96)
- Asia (155)
- Europe (64)
- Latin America (109)
- Middle East (28)
- Multiregional (103)
- North America (43)
- Oceania (9)
